Tag Archives: TSLA

Top 5 Casino Stocks To Buy For 2019

Perhaps it is because trading stocks can often mirror the thrill of winning big at the blackjack tables, or maybe it is because Las Vegas conjures images of the world’s most flashy brands and businessmen. Regardless of the reason, it is clear that gambling stocks are always among the most popular on Wall Street.

Luckily for investors, now is also an interesting time to be buying gambling stocks, as continued Vegas strength, legalized sports gambling coming to the U.S., and an overall international interest in gaming has created some interesting buying opportunity.

Of course, no industries are without risk, and recently, some casino giants have been selling off as gambling data has hinted at a potential slowdown in Macau after an extended recovery in the world’s top gaming hotspot.

Still, we can use Zacks’ proven stock-picking methods to find solid stocks in any industry. Check out these casino stocks today:

1. Penn National Gaming, Inc. (PENN )

Top 5 Casino Stocks To Buy For 2019: Natural Grocers by Vitamin Cottage, Inc.(NGVC)

Advisors’ Opinion:

  • [By Brian Stoffel]

    But over the past five years, the industry has been turned upside down by changes in business models, a focus on delivery, and mass consolidation. While the dust is far from settled, here are 10 of the largest publicly traded grocers you can buy stock in.

    Company Market Cap Stores Regions Chains
    Amazon (NASDAQ:AMZN) $780 billion 500 USA Whole Foods
    Walmart (NYSE:WMT) $250 billion 11,700 Worldwide Walmart
    Costco (NASDAQ:COST) $86 billion 750 USA Costco
    Kroger (NYSE:KR) $21 billion 2,800 USA Kroger, Roundy’s, Ralph’s, Food 4 Less
    Sprouts (NASDAQ: SFM) $3 billion 300 Western and Southern U.S. Sprouts Farmer’s Market
    Weis Market (NYSE: WMK) $1.3 billion 200 Mid-Atlantic U.S. Weis Market
    SUPERVALU (NYSE: SVU) $630 million 100 Midwestern U.S. Cub Foods, Shopper’s Food, Hornbacher
    Ingles Market (NASDAQ: IMKTA) $580 million 200 Southeastern U.S. Ingles Market, Sav-Mor
    Smart & Final (NYSE: SFS) $360 million 350 Western U.S. Smart & Final, Cash & Carry
    Natural Grocers (NYSE: NGVC) $230 million 150 Western U.S. Natural Grocers

    Data source: Yahoo! Finance, company websites.

  • [By Shane Hupp]

    ILLEGAL ACTIVITY WARNING: “Natural Grocers by Vitamin Cottage Sees Unusually Large Options Volume (NGVC)” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/4145368/natural-grocers-by-vitamin-cottage-sees-unusually-large-options-volume-ngvc.html.

  • [By Logan Wallace]

    Ahold Delhaize (OTCMKTS: ADRNY) and Vitamin Cottage Natural Grocers (NYSE:NGVC) are both consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Natural Grocers by Vitamin Cottage (NYSE:NGVC) from a buy rating to a strong-buy rating in a research note released on Tuesday.

  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings.
    Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share.
    California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings.
    Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results.
    Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter.
    Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results.
    Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results.
    B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings.
    HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r
  • [By Motley Fool Transcribers]

    Natural Grocers by Vitamin Cottage Inc  (NYSE:NGVC)Q1 2019 Earnings Conference CallFeb. 07, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Casino Stocks To Buy For 2019: National Commerce Corporation(NCOM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Citigroup Inc. trimmed its holdings in shares of National Commerce Corp (NASDAQ:NCOM) by 44.5% in the first quarter, Holdings Channel reports. The institutional investor owned 2,703 shares of the financial services provider’s stock after selling 2,171 shares during the period. Citigroup Inc.’s holdings in National Commerce were worth $118,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    The Manufacturers Life Insurance Company boosted its holdings in shares of National Commerce Corp (NASDAQ:NCOM) by 0.8% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 223,067 shares of the financial services provider’s stock after acquiring an additional 1,798 shares during the quarter. The Manufacturers Life Insurance Company owned 1.29% of National Commerce worth $9,714,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    National Commerce (NASDAQ:NCOM) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday.

Top 5 Casino Stocks To Buy For 2019: Tesla Motors, Inc.(TSLA)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    In November 2017, Tesla’s (NASDAQ:TSLA) Elon Musk unveiled the Tesla Semi to much fanfare. It sparked a discussion about the transformative potential to electrify long-haul trucking. Transportation is responsible for 27% of America’s total carbon emissions, and medium- and heavy-duty trucks account for 23% of transportation’s total carbon output. Replace diesels with zero-emission engines, and you’d drop U.S. carbon emissions over 6%. 

  • [By ]

    Come on, for real? Standard & Poor’s has raised its corporate credit rating on dying Sears Holdings Corp. (SHLD) to CCC- from SD. S&P gave Sears a shout-out for its “demonstrated progress” on cost reductions and access to new liquidity (thank you majority shareholder, Eddie Lampert). The ratings agency did leave its outlook negative. The only thing that should be raised at Sears are the cranes to knock down all the properties that were once thriving stores. Those cranes could then help turn the properties into high-return assets, say Tesla (TSLA) semi truck dealerships or Amazon Echo stores. Sears has not earned any form of upgrade, on anything, and it’s financial position remains very precarious. The company’s day of reckoning is fast-approaching and if you thought the Toys ‘R’ Us bankruptcy was big news, wait until you see the reports about Sears’ final days. 

  • [By Rich Smith]

    Again, this seems an ambitious schedule for a major urban public transportation project. Still, if Musk can pull it off, the Chicago Loop project could provide a financial boost to Musk’s most famous company, Tesla (NASDAQ:TSLA). TBC has confirmed that it will be buying the pods that will run passengers through Loop’s tunnels from Tesla. Depending on how many pods we’re talking about (and it could be a lot, to accommodate those 80 million O’Hare passengers), that could mean a sizable revenue boost for Tesla, albeit along with attendant capital investment costs to build the new type of vehicle.

Top 5 Casino Stocks To Buy For 2019: Brunswick Corporation(BC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brunswick (BC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Rich Duprey]

    Pontoon boats are a versatile vessel as they can be used for fishing, sports, cruising, and day trips. That latter part is key because rival boatmaker Brunswick (NYSE:BC) — which Polaris used to have a business relationship with when it was in the marine market — says that overnight trips with boats are fading. Industry site Boat Industry quotes Brunswick’s freshwater boat group President Jeff Kinsey as saying, “There’s been a clear shift toward day boating, and that speaks directly to the pontoon with its seating capacity, its open space, its amenities and its comfort.”

  • [By Motley Fool Transcribing]

    Brunswick (NYSE:BC) Q4 2018 Earnings Conference CallJan. 31, 2019 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY WARNING: “$1.15 Billion in Sales Expected for Brunswick Co. (BC) This Quarter” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at www.tickerreport.com/banking-finance/3380347/1-15-billion-in-sales-expected-for-brunswick-co-bc-this-quarter.html.

  • [By Shane Hupp]

    Shares of Brunswick Co. (NYSE:BC) have been given a consensus recommendation of “Buy” by the eighteen brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and fourteen have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $71.33.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brunswick (BC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Casino Stocks To Buy For 2019: SmartFinancial, Inc.(SMBK)

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub lowered shares of SmartFinancial (NASDAQ:SMBK) from a hold rating to a sell rating in a research note published on Thursday morning.

    A number of other analysts have also weighed in on SMBK. Zacks Investment Research upgraded SmartFinancial from a sell rating to a buy rating and set a $21.00 target price on the stock in a research note on Wednesday, January 16th. FIG Partners began coverage on SmartFinancial in a report on Friday, February 22nd. They issued an outperform rating for the company. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the stock. The company has an average rating of Hold and an average price target of $24.60.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on SmartFinancial (SMBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    News coverage about SmartFinancial (NASDAQ:SMBK) has been trending somewhat positive recently, Accern reports. Accern scores the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. SmartFinancial earned a news impact score of 0.21 on Accern’s scale. Accern also assigned media headlines about the bank an impact score of 45.2295427650778 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Stephan Byrd]

    Media coverage about SmartFinancial (NASDAQ:SMBK) has been trending somewhat positive this week, Accern Sentiment reports. The research group ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. SmartFinancial earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news stories about the bank an impact score of 45.289677526379 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Ethan Ryder]

    SmartFinancial (NASDAQ:SMBK) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Friday.

Best High Tech Stocks For 2019

LISTEN TO ARTICLE 2:16 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

Bahrain and its Gulf Arab allies are said to be making progress on an aid program to help the island-kingdom repair its finances and avoid a devaluation that could roil neighboring markets.

Officials from Bahrain, Saudi Arabia, the United Arab Emirates and Kuwait are discussing a multi-year program that would involve spending cuts and measures to increase non-oil revenue, including the introduction of a value-added tax, according to five people with knowledge of the matter. They asked not to be identified because the details aren’t public.

Best High Tech Stocks For 2019: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Starbucks Corp. (NYSE: SBUX) fell about 1.1% Tuesday to post a new 52-week low of $50.11. Shares closed at $50.66 on Monday. The 52-week high is $61.94. Volume of around 10 million was about 3% higher than the daily average. The company had no specific news but a rival chain is stepping in to open new stores.

  • [By Billy Duberstein]

    After stagnating over the course of two and half years, Starbucks (NASDAQ:SBUX) stock is showing signs of perking up. In fact, since its summer swoon, better-than-expected earnings have catapulted shares a handsome 40% off their July 2018 lows.

  • [By Douglas A. McIntyre]

    Starbucks Corp. (NASDAQ: SBUX) has a new benefit for employees: child and adult care support. With a company called Care.com, it will start a new program. And the prices to Starbucks employees will be very low.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Starbucks (SBUX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Daniel B. Kline]

    Visit nearly any Starbucks (NASDAQ:SBUX) at almost any time of day, and you’ll see proof that the company has succeeded in its goal of becoming a “third place” — a social center beyond the home or the workplace. Its tables may be occupied by people working on novels, groups of friends chatting, businesspeople conducting meetings, and maybe even couples on dates.

  • [By Max Byerly]

    Gabelli Funds LLC raised its holdings in Starbucks (NASDAQ:SBUX) by 33.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 433,317 shares of the coffee company’s stock after acquiring an additional 109,000 shares during the quarter. Gabelli Funds LLC’s holdings in Starbucks were worth $25,085,000 as of its most recent filing with the Securities and Exchange Commission.

Best High Tech Stocks For 2019: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Max Byerly]

    Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Anthera Pharmaceuticals alerts:

    Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)

    ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.

  • [By Logan Wallace]

    Aerohive Networks Inc (NYSE:HIVE) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 573,420 shares, a drop of 35.3% from the May 31st total of 885,671 shares. Based on an average trading volume of 381,201 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.8% of the shares of the stock are short sold.

  • [By ]

    Our Biggest Loser… And A Bunch Of Big Wins
    Our biggest loser was back in January when we closed out of small communications equipment firm Aerohive Networks (Nasdaq: HIVE). On January 17, the company made a statement about its upcoming fourth-quarter earnings release, warning that revenue would likely be near the lower end of its guidance range. Investors didn’t take kindly to the news and sent shares tumbling by roughly 30%… well below our 15% trailing stop-loss. We ended up closing out with a 35% loss on the trade.

Best High Tech Stocks For 2019: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Aperio Group LLC increased its position in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) by 49.5% in the first quarter, HoldingsChannel reports. The institutional investor owned 19,270 shares of the biopharmaceutical company’s stock after buying an additional 6,377 shares during the period. Aperio Group LLC’s holdings in Lexicon Pharmaceuticals were worth $165,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Lexicon Pharmaceuticals (LXRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    Sanofi’s also awaiting an FDA decision on sotagliflozin, a drug it licensed from Lexicon Pharmaceuticals (NASDAQ:LXRX) in 2015 for $300 million up front, up to $430 million in development and regulatory milestones, up to $990 million in specified sales milestones, and tiered, escalating royalties ranging from low double-digit percentages to 40% of net sales. 

  • [By Chris Lange]

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) is making presentations at the American Diabetes Association on June 22 to 26. Lexicon recently traded at $13.58 a share, with a consensus analyst price target of $23.00 and a 52-week trading range of $7.67 to $18.00.

  • [By Keith Speights]

    Dividend Yield

    Abbott Laboratories (NYSE:ABT) Drugs $109 billion 19.37 1.88%
    AstraZeneca (NYSE: AZN) Drugs $93 billion 19.70 3.97%
    Becton Dickinson and Co. (NYSE: BDX) Medical supplies $60 billion 17.74 1.29%
    DexCom (NASDAQ: DXCM) Medical devices $8 billion N/A N/A
    Eli Lilly and Co. (NYSE: LLY) Drugs $85 billion 14.91 2.77%
    Insulet (NASDAQ: PODD) Medical devices $5 billion 273.03 N/A
    Johnson & Johnson (NYSE: JNJ) Drugs, medical devices $325 billion 14.16 2.57%
    Lexicon Pharmaceuticals (NASDAQ:LXRX) Drugs $1 billion N/A N/A
    MannKind (NASDAQ: MNKD) Drugs $270 million N/A N/A
    Medtronic (NYSE: MDT) Medical devices $117 billion 15.36 2.14%
    Merck & Co. (NYSE: MRK) Drugs $159 billion 12.99 3.22%
    Novo Nordisk (NYSE:NVO) Drugs $116 billion 18.29 2.61%
    Pfizer (NYSE: PFE) Drugs $209 billion 11.62 3.82%
    Regeneron Pharmaceuticals (NASDAQ: REGN) Drugs $32 billion 13.95 N/A
    Sanofi (NYSE: SNY) Drugs $95 billion 10.75 4.64%
    Senseonics Holdings (NYSEMKT: SENS) Medical devices $447 million N/A N/A
    Tandem Diabetes Care (NASDAQ: TNDM) Medical devices $711 million N/A N/A

    Data source: Yahoo! Finance. P/E = price-to-earnings ratio; N/A = not applicable. Data as of May 25, 2018.

Best High Tech Stocks For 2019: NeoGenomics, Inc.(NEO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on NeoGenomics (NEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    NEO (CURRENCY:NEO) traded up 3.5% against the dollar during the 1-day period ending at 16:00 PM Eastern on October 8th. NEO has a market capitalization of $1.21 billion and $161.27 million worth of NEO was traded on exchanges in the last day. One NEO coin can currently be purchased for approximately $18.64 or 0.00280368 BTC on major cryptocurrency exchanges including LBank, ZB.COM, Gate.io and Allcoin. In the last seven days, NEO has traded up 0.6% against the dollar.

  • [By Joseph Griffin]

    These are some of the media stories that may have effected Accern’s analysis:

    Get NeoGenomics alerts:

    NeoGenomics (NEO) Receives Buy Rating from Stephens (americanbankingnews.com) NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock (finance.yahoo.com) Q2 2018 EPS Estimates for NeoGenomics, Inc. Cut by William Blair (NEO) (americanbankingnews.com) NeoGenomics (NEO) Receives Buy Rating from BTIG Research (americanbankingnews.com) Steven C. Jones Sells 2,000 Shares of NeoGenomics, Inc. (NEO) Stock (americanbankingnews.com)

    NeoGenomics traded up $0.40, hitting $13.90, during trading on Tuesday, MarketBeat Ratings reports. 6,150 shares of the company’s stock traded hands, compared to its average volume of 498,468. NeoGenomics has a 52 week low of $7.08 and a 52 week high of $14.18. The company has a quick ratio of 1.85, a current ratio of 2.03 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $1.13 billion, a P/E ratio of 231.50, a price-to-earnings-growth ratio of 6.69 and a beta of 0.48.

  • [By Ethan Ryder]

    BidaskClub lowered shares of NeoGenomics (NASDAQ:NEO) from a strong-buy rating to a buy rating in a research note published on Wednesday.

    Several other equities research analysts have also weighed in on the company. Leerink Swann began coverage on NeoGenomics in a report on Tuesday, August 21st. They issued an outperform rating and a $18.00 price objective for the company. Zacks Investment Research lowered NeoGenomics from a hold rating to a sell rating in a report on Thursday, July 19th. First Analysis set a $16.00 target price on NeoGenomics and gave the company a buy rating in a report on Tuesday, September 18th. BTIG Research reaffirmed a buy rating and set a $15.00 target price on shares of NeoGenomics in a report on Thursday, June 21st. Finally, Stephens reaffirmed a buy rating and set a $15.00 target price on shares of NeoGenomics in a report on Tuesday, June 26th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of Buy and an average target price of $19.25.

Best High Tech Stocks For 2019: Tesla Motors, Inc.(TSLA)

Advisors’ Opinion:

  • [By John Rosevear]

    This is an important deal. Tesla’s (NASDAQ:TSLA) Supercharger network has given it a big advantage in winning buyers away from internal-combustion alternatives. Any company looking to challenge Tesla will be at a disadvantage unless it can also provide its buyers with assurance that they’ll be able to access high-speed chargers on road trips. 

  • [By ]

    The solution to this problem — that is, night — is to build huge batteries, something that so far has been a real challenge. Right now, Tesla (Nasdaq: TSLA) has the world’s largest battery, a 100-megawatt beauty in Australia, about the size of a U.S. football field. That makes for a lot o’ juice. Enough, in fact, to power 30,000 homes.

  • [By John Rosevear]

    General Motors (NYSE:GM) and Honda Motor (NYSE:HMC) announced that they plan to team up on advanced batteries for electric vehicles in a bid to push back against Tesla (NASDAQ:TSLA) and its massive Gigafactory.

  • [By Rich Smith]

    I dusted off my crystal ball earlier this year and made three (I thought not very) bold predictions about what investors could expect from Tesla (NASDAQ:TSLA) stock in 2018. As we approach the midpoint mark of the year, however, it looks like I’m batting only .333:

Best High Tech Stocks For 2019: OraSure Technologies, Inc.(OSUR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Integra Lifesciences (NASDAQ: OSUR) and OraSure Technologies (NASDAQ:OSUR) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OraSure Technologies (OSUR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) have been given an average rating of “Buy” by the seven research firms that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $20.00.

  • [By Max Byerly]

    SurModics (NASDAQ: OSUR) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, earnings, profitability and analyst recommendations.

Tuesday’s Vital Data: Apple Inc. (AAPL), Tesla Inc (TSLA) and JD.com Inc(ADR) (JD)

U.S. stock futures are trading broadly lower this morning. Once again, market sentiment is dependent on President Trump, as traders await his decision on the Iran nuclear deal this afternoon.

Tuesday's Vital Data: Apple Inc., Tesla Inc and JD.com, Inc.Furthermore, oil prices are down 1% below $70 per barrel this morning. Futures traders appear to be betting that Trump will pull out of the Iran deal.

Heading into the open, futures on the Dow Jones Industrial Average are down 0.21%, S&P 500 futures have fallen 0.26% and Nasdaq-100 futures have lost 0.33%.

Turning to the options pits, volume was anemic, arriving at its lowest levels in weeks. Only about 16.9 million calls and 13.1 million puts crossed the tape. On the CBOE, the light volume led to another drop in the single-session equity put/call volume ratio, which fell to 0.54. The 10-day moving average ticked lower to 0.64.

Options traders were reserved on Monday, choosing to stick to big names like Apple Inc. (NASDAQ:AAPL) and Warren Buffett’s renewed interest in the company. Additionally, the fallout from Tesla Inc’s (NASDAQ:TSLA) post-earnings conference call powered bullish options activity. Finally, JD.com, Inc. (NYSE:JD) call options were active ahead of this morning’s quarterly report.

Let’s take a closer look:

Tuesday's Vital Options Data: Apple Inc. (AAPL), Tesla Inc. (TSLA) and JD.com, Inc. (JD)investorplace.com/wp-content/uploads/2018/05/05-08-2018-Top-Ten-Options-300×164.png 300w, investorplace.com/wp-content/uploads/2018/05/05-08-2018-Top-Ten-Options-200×109.png 200w, investorplace.com/wp-content/uploads/2018/05/05-08-2018-Top-Ten-Options-162×88.png 162w, investorplace.com/wp-content/uploads/2018/05/05-08-2018-Top-Ten-Options-400×219.png 400w, investorplace.com/wp-content/uploads/2018/05/05-08-2018-Top-Ten-Options-116×63.png 116w, investorplace.com/wp-content/uploads/2018/05/05-08-2018-Top-Ten-Options-100×55.png 100w,https://investorplace.com/wp-content/uploads/2018/05/05-08-2018-Top-Ten-Options-91×50.png 91w, investorplace.com/wp-content/uploads/2018/05/05-08-2018-Top-Ten-Options-78×43.png 78w, investorplace.com/wp-content/uploads/2018/05/05-08-2018-Top-Ten-Options-414×227.png 414w” sizes=”(max-width: 415px) 100vw, 415px” />

Apple Inc. (AAPL)

The Oracle of Omaha continued to drive AAPL stock higher on Monday. Last week, Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK-B) disclosed it bought $75 million in Apple stock in the first quarter. Yesterday, Buffett himself chimed in on Apple stock:

“I clearly like Apple. We buy them to hold,” Buffett told CNBC. “We bought about 5% of the company. I’d love to own 100% of it.”

AAPL shares rose to all-time highs following the comments, putting the company closer to a $1 trillion valuation. Options traders chased the shares higher.

Volume soared to 769,000 contracts despite the light volume session. Call options made up an above average 68% of the day’s take.

Short-term traders, however, are looking for a pullback. Currently, the May put/call open interest ratio rests at 1.29, with puts firmly in command of the near-term outlook.

Tesla Inc (TSLA)

Tesla CEO Elon Musk stirred up quite a controversy last week by lashing out at speculative day traders and short sellers last week. The comments overshadowed an otherwise solid quarterly earnings report. I believe that Musk did Tesla investors a favor with his candor, but that hasn’t stopped the financial media or the brokerage community from piling on.

Cash burn is the biggest concern for Tesla, according to analysts at CreditSights. The ratings firm yesterday claimed that Tesla’s “cash bleed” would probably double in the second quarter as the company ramps up Model 3 production.

Compare Brokers

But Tesla options traders have “been there, done that.” Instead, traders chose to focus on TSLA’s move back above $300, as calls claimed 58% of the more than 192,000 contracts traded yesterday.

But while optimism is growing, the May put/call OI ratio still rests at 1.25. With puts firmly entrenched in near-term OI configurations, it may take some time before this negativity is wrung out of the system.

JD.com, Inc. (JD)

Apparently 61% year-over-year revenue growth just isn’t fast enough for Wall Street. JD.com, the No. 2 e-commerce company in China, reported this morning that second-quarter revenue soared to 45.9 billion yuan ($7.4 billion), topping expectations. However, JD said it sees third-quarter revenue of between 43.2 and 44.7 billion yuan, up about 49% to 54% year over year and down from the prior quarter growth rate.

As a result, JD stock is volatile this morning, swinging from a loss of about 3% to up nearly 1% at last check. Options traders were clearly expecting a post-earnings rally, however.

Volume yesterday rose to 175,000 contracts, with calls gobbling up 75% of the day’s take. JD’s May put/call OI ratio rests at 0.75, which is down sharply from last month’s perch above 1. JD is still down about 12% since late January, and today’s earnings could still provide ballast.

As of this writing, Joseph Hargett held no positions on any of the aforemen

3 Earnings Season Highlights From Automakers

Earnings season is always hectic, fun, and full of information from all angles of any given industry. This time around, the automotive industry had quite an interesting first quarter: There were some wild comments from Tesla(NASDAQ:TSLA) CEO Elon Musk, as well as a bold decision from Ford Motor Company (NYSE:F), and an intriguing partnership deal fromAptiv (NYSE:APTV). Here’s what investors need to know.

A not-so-boring call

Tesla’s conference calls are never boring, and are generally full of information, hype, and intrigue. This one was no exception, albeit a little more bizarre than analysts expected.

Musk expressed annoyance with the discussion of accounting figures and what he deemed myopic questions — exactly what Wall Street cares about from quarter to quarter. It’s not difficult to understand his frustration, given his ambitions are much grander. Unfortunately, Musk became fed up, telling the operator that “Boring, bonehead questions are not cool. Next?” Musk later replied to another question with: “I’m not here to convince you to buy our stock. Do not buy it if volatility is scary. There you go.”

That’s just a small sample from the unique conference call.

But don’t let those comments overshadow Tesla — a company that has the potential to become an electric-vehicle empire — and some of its interesting figures from the quarter. Among them, Tesla revealed it had more than 450,000 Model 3 reservations at the end of the first quarter, and that it hoped to reach production of 5,000 per week in roughly two months (production hit 2,270 per week during April). And the company said it could begin production of the Model Y small crossover in early 2020.

On the downside, while the future could be incredibly bright, Tesla reported a net loss of $784.6 million and its cash flow was negative $1 billion for the third time in the past four quarters.

What we learned: Musk and Tesla will continue to think big, Wall Street will remain myopic, and the electric-vehicle maker’s conference calls will never be boring.

Farewell, cars

What’s a Detroit automaker without a passenger-car lineup? In 2008, then-CEO of Ford Alan Mulally might have said “shortsighted.” Today, CEO Jim Hackett would say something along the lines of… “a healthier Detroit automaker.”It sounds crazy, and it’s at least risky, but Ford announced it would soon stop selling most of its passenger-car lineup in the U.S. market, which is craving more SUVs, crossovers, and trucks. Only Ford’s Mustang will remain, along with the Focus Active, which will arrive in 2019 as a wagon version in lower volumes.

Ford anticipates that by the end of 2020, light trucks will generate 90% of its North American sales — that’s certainly one way to boost margins. The decision is part of Ford’s strategy to get “fit,” which essentially means to feed the healthy parts of the business and cut costs. On the latter point, last October Ford was aiming at cutting $14 billion in costs; it then updated that by targeting $25.5 billion in savings by 2022.

A blue Ford F-150 towing a boat

Ford’s F-150 hauls big bucks for the company. Image source: Ford Motor Company.

It’s a high-risk, high-reward strategy. UBS analyst Colin Langan estimates Ford loses $800 million annually selling light cars, according to Automotive News, and that would filter down nicely to Ford’s bottom line. However, the company also risks losing a customer base looking for an entry-level-priced vehicle, and of course there’s the risk of consumer demand switching away from larger vehicles. We’ll see how it shakes out.

It’s possible Ford could bend on this strategy. But the decision is certainly the wildest move under Hackett so far, and one of the most interesting takeaways from this earnings season.

The future is now

Many investors haven’t heard of Aptiv yet — formerly Delphi Automotive — but almost certainly will in the decades ahead. Aptiv is uniquely positioned to deliver end-to-end smart-mobility and driverless-vehicle technology solutions. We don’t yet know which service providers (think Uber and Lyft) will win market share, or which automakers (think Ford and General Motors) will develop the best electric fleets or driverless vehicles, or how Silicon Valley will play its angle. But Aptiv will be involved in many aspects as a supplier.

That became even more clear Wednesday when it announced a small project with Lyft. The company said it would launch a fleet of 30 autonomous vehicles in Las Vegas on the Lyft network; passengers will have the ability to hail a self-driving vehicle equipped with Aptiv technology to go between high-demand locations.

It’s projects like this that will enable companies to figure out exactly how they can monetize big data, services, and driverless technology, as those all intersect in the evolving automotive industry. It’s unclear how it will all shake out, how soon this market will become lucrative, and which companies will rise to the top to the benefit of their investors. But this small project between Aptiv and Lyft makes it clear that the future of driverless cars is on its way, soon.

Earnings season is always crazy, and always exciting, and the first quarter of 2018 was no different. When you have a CEO losing patience with financial questions, Detroit’s second-largest automaker giving up on cars in the U.S., and driverless-car projects getting underway, you know it’s going to be an interesting year and decade. The industry is likely to evolve more over the next two decades than it has over the past century — and that could be very lucrative to savvy investors.

3 Earnings Season Highlights From Automakers

Earnings season is always hectic, fun, and full of information from all angles of any given industry. This time around, the automotive industry had quite an interesting first quarter: There were some wild comments from Tesla(NASDAQ:TSLA) CEO Elon Musk, as well as a bold decision from Ford Motor Company (NYSE:F), and an intriguing partnership deal fromAptiv (NYSE:APTV). Here’s what investors need to know.

A not-so-boring call

Tesla’s conference calls are never boring, and are generally full of information, hype, and intrigue. This one was no exception, albeit a little more bizarre than analysts expected.

Musk expressed annoyance with the discussion of accounting figures and what he deemed myopic questions — exactly what Wall Street cares about from quarter to quarter. It’s not difficult to understand his frustration, given his ambitions are much grander. Unfortunately, Musk became fed up, telling the operator that “Boring, bonehead questions are not cool. Next?” Musk later replied to another question with: “I’m not here to convince you to buy our stock. Do not buy it if volatility is scary. There you go.”

That’s just a small sample from the unique conference call.

But don’t let those comments overshadow Tesla — a company that has the potential to become an electric-vehicle empire — and some of its interesting figures from the quarter. Among them, Tesla revealed it had more than 450,000 Model 3 reservations at the end of the first quarter, and that it hoped to reach production of 5,000 per week in roughly two months (production hit 2,270 per week during April). And the company said it could begin production of the Model Y small crossover in early 2020.

On the downside, while the future could be incredibly bright, Tesla reported a net loss of $784.6 million and its cash flow was negative $1 billion for the third time in the past four quarters.

What we learned: Musk and Tesla will continue to think big, Wall Street will remain myopic, and the electric-vehicle maker’s conference calls will never be boring.

Farewell, cars

What’s a Detroit automaker without a passenger-car lineup? In 2008, then-CEO of Ford Alan Mulally might have said “shortsighted.” Today, CEO Jim Hackett would say something along the lines of… “a healthier Detroit automaker.”It sounds crazy, and it’s at least risky, but Ford announced it would soon stop selling most of its passenger-car lineup in the U.S. market, which is craving more SUVs, crossovers, and trucks. Only Ford’s Mustang will remain, along with the Focus Active, which will arrive in 2019 as a wagon version in lower volumes.

Ford anticipates that by the end of 2020, light trucks will generate 90% of its North American sales — that’s certainly one way to boost margins. The decision is part of Ford’s strategy to get “fit,” which essentially means to feed the healthy parts of the business and cut costs. On the latter point, last October Ford was aiming at cutting $14 billion in costs; it then updated that by targeting $25.5 billion in savings by 2022.

A blue Ford F-150 towing a boat

Ford’s F-150 hauls big bucks for the company. Image source: Ford Motor Company.

It’s a high-risk, high-reward strategy. UBS analyst Colin Langan estimates Ford loses $800 million annually selling light cars, according to Automotive News, and that would filter down nicely to Ford’s bottom line. However, the company also risks losing a customer base looking for an entry-level-priced vehicle, and of course there’s the risk of consumer demand switching away from larger vehicles. We’ll see how it shakes out.

It’s possible Ford could bend on this strategy. But the decision is certainly the wildest move under Hackett so far, and one of the most interesting takeaways from this earnings season.

The future is now

Many investors haven’t heard of Aptiv yet — formerly Delphi Automotive — but almost certainly will in the decades ahead. Aptiv is uniquely positioned to deliver end-to-end smart-mobility and driverless-vehicle technology solutions. We don’t yet know which service providers (think Uber and Lyft) will win market share, or which automakers (think Ford and General Motors) will develop the best electric fleets or driverless vehicles, or how Silicon Valley will play its angle. But Aptiv will be involved in many aspects as a supplier.

That became even more clear Wednesday when it announced a small project with Lyft. The company said it would launch a fleet of 30 autonomous vehicles in Las Vegas on the Lyft network; passengers will have the ability to hail a self-driving vehicle equipped with Aptiv technology to go between high-demand locations.

It’s projects like this that will enable companies to figure out exactly how they can monetize big data, services, and driverless technology, as those all intersect in the evolving automotive industry. It’s unclear how it will all shake out, how soon this market will become lucrative, and which companies will rise to the top to the benefit of their investors. But this small project between Aptiv and Lyft makes it clear that the future of driverless cars is on its way, soon.

Earnings season is always crazy, and always exciting, and the first quarter of 2018 was no different. When you have a CEO losing patience with financial questions, Detroit’s second-largest automaker giving up on cars in the U.S., and driverless-car projects getting underway, you know it’s going to be an interesting year and decade. The industry is likely to evolve more over the next two decades than it has over the past century — and that could be very lucrative to savvy investors.